Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3752 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

MedImmune rebuffs sale talk

The company said that it had received a letter from shareholder David Katz, president of Matrix Asset Advisors, commenting on the company's quarterly results and suggesting that MedImmune

Mylan generic hypertension drug authorized

The tablets have been approved in different strengths, including 60mg, 80mg, 120mg and 160mg. Propranolol hydrochloride extended-release (ER) capsules are the generic version of Wyeth Pharmaceutical’s Inderal LA,